MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology
MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology
Laparoscopy, now virtually completely, was replaced with robotic surgery in uro-oncological
 surgery in the world. And given the significant increase in the number of robotic surgeries
 for prostate, bladder and kidney cancer, it is now a major domain in oncological surgery.
 Microport MedBot Inc. has independently developed a domestic surgical robot in China.
 Therefore, the purpose of the study is to evaluate the safety and efficacy of the Chinese
 robot when applied to surgery in oncology.
Inclusion Criteria:

 -  be aged between 18 years and 80 years;

 -  laparoscopic surgery is required with one of the following surgical
 indications:(1)planning to perform radical prostatectomy(clinical stage is T1 or
 T2,and PSA≥ 0.2ng/mL) ;(2) planning to perform nephrectomy

 -  being able to cooperate and complete the follow-up and related examinations;

 -  volunteer to participate in this study and sign the informed consent.

 Exclusion Criteria:

 -  patients requiring emergency surgery;

 -  have severe cardiovascular or circulatory disease and cannot tolerate surgery;

 -  participated in other clinical trials in the last 3 months;

 -  failure to understand study requirements